INOVIO PHARMACEUTICALS, INC. Stock Split Ratio
INOVIO PHARMACEUTICALS, INC. (INO) reported Stock Split Ratio of 8.33% for the 1-month period ending 2024-01-31, per its 10-Q filed 2024-11-14.
Financial Statements › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-03-18
- 2024-01-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 8.33%.
- 2024-01-24: Stockholders' Equity Note, Stock Split, Conversion Ratio 8.33%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 8.33%.
- 2014-06-05: Stockholders' Equity Note, Stock Split, Conversion Ratio 25.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|---|
| 2024-01-31 | 8.33% 10-Q · filed 2024-11-14 | ||
| 2024-01-24 | 8.33% 10-K · filed 2025-03-18 | 8.33% 10-Q · filed 2024-05-13 | |
| 2014-06-05 | 25.00% 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |